Testing different doses of sirolimus for cystic lymphatic malformations
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests different doses of sirolimus (a medication that slows cell growth) to find the best dose for treating cystic lymphatic malformations in children. It may help shrink the abnormal fluid-filled growths and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 0 to 18 years old.
- You have a confirmed diagnosis of cystic lymphatic malformation (a type of abnormal growth filled with fluid).
- You have not taken sirolimus or similar drugs before.
- You have not had other treatments like chemotherapy, embolization, or sclerotherapy in the last week.
- You have no serious infections or medical problems that would make participation unsafe.
- You do not have HIV, a weakened immune system, or a history of cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called bleomycin, injected into lymphatic malformations (abnormal fluid-filled growths) to shrink them. It is for children under 14 whose malformations are growing quickly, causing symptoms or problems, and cannot be removed by surgery alone.
This trial studies whether rapamycin can reduce problems caused by cervico-facial or chest (mediastinal) lymphatic malformations in children. It may help with pain and swallowing or breathing difficulties when standard “curative” treatment isn’t possible.
This trial studies whether taking sirolimus once a week can improve blood vessel, lymph vessel, or mixed (venolymphatic) malformations. It may help reduce symptoms and lesion size, while also monitoring safety in children and adults.
This Phase 2 trial tests whether an injected medicine called TARA-002 placed inside lymphatic cysts can safely shrink lymphatic malformations in children. It may help especially when the cysts are mainly in the head, neck, or chest area.
This study tests whether a low dose or a high dose of sirolimus (a drug that stops abnormal cell growth) combined with prednisolone (a steroid) works better for children with a rare, aggressive vascular tumor called KHE that also causes low blood platelets (KMP). The goal is to find the safest and most effective dose to help shrink the tumor and improve blood counts.
This trial tests if sirolimus can help children with a certain type of eye socket malformation. It aims to find a better treatment for children aged 1 to 18.
Hear when a new Lymphatic Malformation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.